RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
Masamitsu Mikami(Kitano Hospital), Yasuhiko Kamikubo(Kyoto University)
Cited by 5
Related Papers
Genetic regulation of the RUNX transcription factor family has antitumor effects
|Journal of Clinical Investigation|2017|131
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells
|Scientific Reports|2018|40
Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells
|Scientific Reports|2017|36